000 01597 a2200457 4500
005 20250516020021.0
264 0 _c20121016
008 201210s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/jm101273e
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTanaka, Daisuke
245 0 0 _aA practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cFeb 2011
300 _a851-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDatabases, Factual
650 0 4 _aEpoxide Hydrolases
_xantagonists & inhibitors
650 0 4 _aHep G2 Cells
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aMolecular Conformation
650 0 4 _aOxadiazoles
_xchemical synthesis
650 0 4 _aProtein Binding
650 0 4 _aQuantitative Structure-Activity Relationship
650 0 4 _aSolubility
650 0 4 _aStereoisomerism
650 0 4 _aUrea
_xanalogs & derivatives
650 0 4 _aYoung Adult
700 1 _aTsuda, Yusuke
700 1 _aShiyama, Takaaki
700 1 _aNishimura, Tamiki
700 1 _aChiyo, Naoki
700 1 _aTominaga, Yukio
700 1 _aSawada, Nobuyuki
700 1 _aMimoto, Tsutomu
700 1 _aKusunose, Naoto
773 0 _tJournal of medicinal chemistry
_gvol. 54
_gno. 3
_gp. 851-7
856 4 0 _uhttps://doi.org/10.1021/jm101273e
_zAvailable from publisher's website
999 _c20479202
_d20479202